(January 25, 2018) OCRFA has just awarded more than $5.3 million in new scientific research grants for ovarian cancer, bringing our total investment in life-saving research to over $80 million.
This year’s grants have been awarded to twenty top scientists at sixteen leading medical centers across the country.
“Our 2018 grantees are truly some of the most talented researchers in the field today,” said Dr. Jeff Boyd, chair of OCRFA’s Scientific Advisory Committee and director of Translational Research and Genomic Medicine at Miami Cancer Institute.
“Through their hard work and dedication to the cause, we hope to see significant progress that will one day help us find a cure for ovarian cancer.”
Collaborative Research Development Grant Recipients
Gordon Mills, MD, PhD – University of Texas MD Anderson Cancer Center
David Sabatini, MD, PhD – Whitehead Institute for Biomedical Research
Liz Tilberis Early Career Award Recipients
Maria Victoria Botuyan, PhD – Mayo Clinic
Katherine Fuh, MD, PhD – Washington University in St. Louis
Hilary Kenny, PhD – The University of Chicago
Chunsheng Li, PhD – The University of Pennsylvania
Sumegha Mitra, PhD – Indiana University
Jian Yuan, PhD – Mayo Clinic
Ann and Sol Schreiber Mentored Investigator Award Recipients
Damayanti Chakraborty, PhD – Massachusetts General Hospital
Daniele Chaves-Moreira, PhD – The University of Pennsylvania
Chin-Chi Chen, PhD – Johns Hopkins University School of Medicine
Shih-Hsun Chen, PhD – Beckman Research Institute of the City of Hope
Matthew Dean, PhD – University of Illinois at Chicago
Marcela Haro, PhD – Cedars-Sinai Medical Center*
Ye Hu, MD, PhD – Cedars-Sinai Medical Center
Justyna Kanska, PhD – Cedars-Sinai Medical Center
Goldie Lui, PhD – Fred Hutchinson Cancer Research Center
Sarah Stuckelberger, MD – The University of Pennsylvania
Yinu Wang, PhD – Northwestern University
Shuang Zhang, PhD – New York University School of Medicine
*Dr. Haro has replaced a previous 2018 Ann and Sol Schreiber grantee
